Robert A. Budinsky

Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes

Grace Patlewicz, Ted W. Simon, J. Craig Rowlands et al. · Regulatory Toxicology and Pharmacology · 2015 · 106 citations · Full text

Pharmacy, Toxicology, Molecular Toxicology +16

Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice

Joshua Harrill, Renee Hukkanen, Marie Lawson et al. · Toxicology and Applied Pharmacology · 2013 · 83 citations

Medicine, Nephrology, Pharmacology +11

Cross-species Comparisons of Transcriptomic Alterations in Human and Rat Primary Hepatocytes Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin

Michael B. Black, Robert A. Budinsky, Alan A. Dombkowski et al. · Toxicological Sciences · 2012 · 73 citations

Pharmacy, Toxicology, Hepatotoxicology +16

Primaquine-Induced Hemolytic Anemia: Formation and Hemotoxicity of the Arylhydroxylamine Metabolite 6-Methoxy-8-hydroxylaminoquinoline

Laura J. C. Bolchoz, Robert A. Budinsky, David C. McMillan et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 68 citations

Medicine, Pharmacology, Toxicology +13

Automated Dose-Response Analysis and Comparative Toxicogenomic Evaluation of the Hepatic Effects Elicited by TCDD, TCDF, and PCB126 in C57BL/6 Mice

Anna K. Kopec, Lyle D. Burgoon, Daher Ibrahim-Aibo et al. · Toxicological Sciences · 2010 · 61 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +17